DOJ, SEC issue subpoena to Johnson & Johnson over baby product safety

By Nikita Chaurasia  Date: 2019-02-26

DOJ, SEC issue subpoena to Johnson & Johnson over baby product safety

Johnson & Johnson is presently facing lawsuits involving 13,000 plaintiffs.

Pharmaceutical and consumer products giant Johnson & Johnson has confirmed that it has received subpoenas from the U.S. Department of Justice as well as the Securities and Exchange Commission (SEC), with regard to investigations into alleged asbestos contamination in the products from its well-known Baby Powder line.

Apparently, the company aims to fully cooperate with inquiries from the authorities and would keep defending itself against talc product-related litigation. In its annual report issued recently, the company accepted for the first time that it had received subpoenas from U.S. agencies over safety concerns regarding its talc power products, Reuters has mentioned. 

The DOJ and SEC did not seem to have offered any comments for responding to the news. 

A report released in December said that Johnson & Johnson was aware for decades that asbestos, which is a recognized carcinogen, had been found several times in its talc and powder products in small amounts. The company had allegedly failed to disclose this information, found out from tests conducted from 1970s to early 2000s, to the public and the regulators.

Records show that the information revealed had led to Johnson & Johnson shares losing about $40 billion from the market valuation in a single day. It had also triggered a public relations disaster involving worldwide inquiries about probable health effects of its signature product.

For its part, the company has stated that inquiries from federal agencies are based on news reports which consisted of inaccurate statements, besides withholding vital information that were made public already. Johnson & Johnson has insisted that for decades, independent testing performed by regulators and leading laboratories around the world have proven its baby power is asbestos-free, safe to use and does not cause cancer.

For the record, Johnson & Johnson is facing lawsuits involving 13,000 plaintiffs who claim using the company’s talc products, such as Baby Powder, have caused cancer.

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

France might ban short domestic flights to reduce its carbon footprint

France might ban short domestic flights to reduce its carbon footprint

By Nikita Chaurasia

French lawmakers recently came to a unanimous decision to ban domestic flights for distances that can be covered by train in over two-and-a-half- hours. The country aims to impose these restrictions in an effort to reduce carbon emissions, even as th...

Kavak secures USD 485 million in funding, eyes Latin America expansion

Kavak secures USD 485 million in funding, eyes Latin America expansion

By Nikita Chaurasia

Kavak, a Mexico-based used-car platform, has reportedly reached a valuation of USD 4 billion after securing USD 485 million during a new funding round. This makes it the fastest-growing as well as the most valued company in Latin America. The latest...

Zydus seeks DCGI approval for PegIFN drug to treat COVID-19 patients

Zydus seeks DCGI approval for PegIFN drug to treat COVID-19 patients

By Nikita Chaurasia

Indian pharmaceutical company Zydus Cadila is reportedly seeking approval from DCGI (Drug Controller General of India) for its PegIFN (Pegylated Interferon Alpha-2b), a hepatitis C drug, to treat COVID-19 patients, after its third phase of clinical t...

LinkedIn confirms launch of a social audio platform to rival Clubhouse

LinkedIn confirms launch of a social audio platform to rival Clubhouse

By Nikita Chaurasia

LinkedIn, the popular employment-oriented online service, has confirmed that it is testing a social audio experience in its app which could offer users with better connectivity in their networks. Although several social media giants such as Twitter ...

Pfizer begins Phase-1 trials of oral COVID-19 antiviral drug in U.S.

Pfizer begins Phase-1 trials of oral COVID-19 antiviral drug in U.S.

By Nikita Chaurasia

Pfizer Inc., an American multinational pharmaceutical corporation, has recently announced to have started the early phase trials for its oral antiviral drug for Coronavirus. The company revealed that first phase trials of the experimental drug, PF-07...